2025 Adverse Effect ICD-10-CM Codes - Page 3

The 2025 Adverse Effect ICD-10-CM Codes list includes 2,107 codes for documenting harmful or unintended reactions to drugs or substances taken as prescribed or directed. These are not poisonings but side effects from proper use of medications. Coders must identify the specific drug involved and ensure that documentation supports an adverse effect rather than misuse. Reporting adverse effects correctly prevents claim denials and ensures accurate clinical data collection. No external cause code is required.

  • T48.0X1S - Poisoning by oxytocic drugs, accidental (unintentional), sequela Billable

  • T48.0X2S - Poisoning by oxytocic drugs, intentional self-harm, sequela Billable

  • T48.0X3S - Poisoning by oxytocic drugs, assault, sequela Billable

  • T48.0X4S - Poisoning by oxytocic drugs, undetermined, sequela Billable

  • T48.0X5 - Adverse effect of oxytocic drugs Non-Billable

  • T48.0X5A - Adverse effect of oxytocic drugs, initial encounter Billable

  • T48.0X5D - Adverse effect of oxytocic drugs, subsequent encounter Billable

  • T48.0X5S - Adverse effect of oxytocic drugs, sequela Billable

  • T48.0X6S - Underdosing of oxytocic drugs, sequela Billable

  • T48.1X1S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), sequela Billable

  • T48.1X2S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela Billable

  • T48.1X3S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, sequela Billable

  • T48.1X4S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, sequela Billable

  • T48.1X5 - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents] Non-Billable

  • T48.1X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter Billable

  • T48.1X5D - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter Billable

  • T48.1X5S - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela Billable

  • T48.1X6S - Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela Billable

  • T48.201S - Poisoning by unspecified drugs acting on muscles, accidental (unintentional), sequela Billable

  • T48.202S - Poisoning by unspecified drugs acting on muscles, intentional self-harm, sequela Billable

  • T48.203S - Poisoning by unspecified drugs acting on muscles, assault, sequela Billable

  • T48.204S - Poisoning by unspecified drugs acting on muscles, undetermined, sequela Billable

  • T48.205 - Adverse effect of unspecified drugs acting on muscles Non-Billable

  • T48.205A - Adverse effect of unspecified drugs acting on muscles, initial encounter Billable

  • T48.205D - Adverse effect of unspecified drugs acting on muscles, subsequent encounter Billable

  • T48.205S - Adverse effect of unspecified drugs acting on muscles, sequela Billable

  • T48.206S - Underdosing of unspecified drugs acting on muscles, sequela Billable

  • T48.291S - Poisoning by other drugs acting on muscles, accidental (unintentional), sequela Billable

  • T48.292S - Poisoning by other drugs acting on muscles, intentional self-harm, sequela Billable

  • T48.293S - Poisoning by other drugs acting on muscles, assault, sequela Billable

  • T48.294S - Poisoning by other drugs acting on muscles, undetermined, sequela Billable

  • T48.295 - Adverse effect of other drugs acting on muscles Non-Billable

  • T48.295A - Adverse effect of other drugs acting on muscles, initial encounter Billable

  • T48.295D - Adverse effect of other drugs acting on muscles, subsequent encounter Billable

  • T48.295S - Adverse effect of other drugs acting on muscles, sequela Billable

  • T48.296S - Underdosing of other drugs acting on muscles, sequela Billable

  • T48.3X1S - Poisoning by antitussives, accidental (unintentional), sequela Billable

  • T48.3X2S - Poisoning by antitussives, intentional self-harm, sequela Billable

  • T48.3X3S - Poisoning by antitussives, assault, sequela Billable

  • T48.3X4S - Poisoning by antitussives, undetermined, sequela Billable

  • T48.3X5 - Adverse effect of antitussives Non-Billable

  • T48.3X5A - Adverse effect of antitussives, initial encounter Billable

  • T48.3X5D - Adverse effect of antitussives, subsequent encounter Billable

  • T48.3X5S - Adverse effect of antitussives, sequela Billable

  • T48.3X6S - Underdosing of antitussives, sequela Billable

  • T48.4X1S - Poisoning by expectorants, accidental (unintentional), sequela Billable

  • T48.4X2S - Poisoning by expectorants, intentional self-harm, sequela Billable

  • T48.4X3S - Poisoning by expectorants, assault, sequela Billable

  • T48.4X4S - Poisoning by expectorants, undetermined, sequela Billable

  • T48.4X5 - Adverse effect of expectorants Non-Billable

  • T48.4X5A - Adverse effect of expectorants, initial encounter Billable

  • T48.4X5D - Adverse effect of expectorants, subsequent encounter Billable

  • T48.4X5S - Adverse effect of expectorants, sequela Billable

  • T48.4X6S - Underdosing of expectorants, sequela Billable

  • T48.5X1S - Poisoning by other anti-common-cold drugs, accidental (unintentional), sequela Billable

  • T48.5X2S - Poisoning by other anti-common-cold drugs, intentional self-harm, sequela Billable

  • T48.5X3S - Poisoning by other anti-common-cold drugs, assault, sequela Billable

  • T48.5X4S - Poisoning by other anti-common-cold drugs, undetermined, sequela Billable

  • T48.5X5 - Adverse effect of other anti-common-cold drugs Non-Billable

  • T48.5X5A - Adverse effect of other anti-common-cold drugs, initial encounter Billable

  • T48.5X5D - Adverse effect of other anti-common-cold drugs, subsequent encounter Billable

  • T48.5X5S - Adverse effect of other anti-common-cold drugs, sequela Billable

  • T48.5X6S - Underdosing of other anti-common-cold drugs, sequela Billable

  • T48.6X1S - Poisoning by antiasthmatics, accidental (unintentional), sequela Billable

  • T48.6X2S - Poisoning by antiasthmatics, intentional self-harm, sequela Billable

  • T48.6X3S - Poisoning by antiasthmatics, assault, sequela Billable

  • T48.6X4S - Poisoning by antiasthmatics, undetermined, sequela Billable

  • T48.6X5 - Adverse effect of antiasthmatics Non-Billable

  • T48.6X5A - Adverse effect of antiasthmatics, initial encounter Billable

  • T48.6X5D - Adverse effect of antiasthmatics, subsequent encounter Billable

  • T48.6X5S - Adverse effect of antiasthmatics, sequela Billable

  • T48.6X6S - Underdosing of antiasthmatics, sequela Billable

  • T48.901S - Poisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), sequela Billable

  • T48.902S - Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, sequela Billable

  • T48.903S - Poisoning by unspecified agents primarily acting on the respiratory system, assault, sequela Billable

  • T48.904S - Poisoning by unspecified agents primarily acting on the respiratory system, undetermined, sequela Billable

  • T48.905 - Adverse effect of unspecified agents primarily acting on the respiratory system Non-Billable

  • T48.905A - Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter Billable

  • T48.905D - Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter Billable

  • T48.905S - Adverse effect of unspecified agents primarily acting on the respiratory system, sequela Billable

  • T48.906S - Underdosing of unspecified agents primarily acting on the respiratory system, sequela Billable

  • T48.991S - Poisoning by other agents primarily acting on the respiratory system, accidental (unintentional), sequela Billable

  • T48.992S - Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, sequela Billable

  • T48.993S - Poisoning by other agents primarily acting on the respiratory system, assault, sequela Billable

  • T48.994S - Poisoning by other agents primarily acting on the respiratory system, undetermined, sequela Billable

  • T48.995A - Adverse effect of other agents primarily acting on the respiratory system, initial encounter Billable

  • T48.995D - Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter Billable

  • T48.995S - Adverse effect of other agents primarily acting on the respiratory system, sequela Billable

  • T48.996S - Underdosing of other agents primarily acting on the respiratory system, sequela Billable

  • T46.0X1S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela Billable

  • T46.0X2S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela Billable

  • T46.0X3S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela Billable

  • T46.0X4S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela Billable

  • T46.0X5 - Adverse effect of cardiac-stimulant glycosides and drugs of similar action Non-Billable

  • T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter Billable

  • T46.0X5D - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter Billable

  • T46.0X5S - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela Billable

  • T46.0X6S - Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela Billable

  • T46.1X1S - Poisoning by calcium-channel blockers, accidental (unintentional), sequela Billable

  • T46.1X2S - Poisoning by calcium-channel blockers, intentional self-harm, sequela Billable

  • T46.1X3S - Poisoning by calcium-channel blockers, assault, sequela Billable

  • T46.1X4S - Poisoning by calcium-channel blockers, undetermined, sequela Billable

  • T46.1X5 - Adverse effect of calcium-channel blockers Non-Billable

  • T46.1X5A - Adverse effect of calcium-channel blockers, initial encounter Billable

  • T46.1X5D - Adverse effect of calcium-channel blockers, subsequent encounter Billable

  • T46.1X5S - Adverse effect of calcium-channel blockers, sequela Billable

  • T46.1X6S - Underdosing of calcium-channel blockers, sequela Billable

  • T46.2X1S - Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela Billable

  • T46.2X2S - Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela Billable

  • T46.2X3S - Poisoning by other antidysrhythmic drugs, assault, sequela Billable

  • T46.2X4S - Poisoning by other antidysrhythmic drugs, undetermined, sequela Billable

  • T46.2X5 - Adverse effect of other antidysrhythmic drugs Non-Billable

  • T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter Billable

  • T46.2X5D - Adverse effect of other antidysrhythmic drugs, subsequent encounter Billable

  • T46.2X5S - Adverse effect of other antidysrhythmic drugs, sequela Billable

  • T46.2X6S - Underdosing of other antidysrhythmic drugs, sequela Billable

  • T46.3X1S - Poisoning by coronary vasodilators, accidental (unintentional), sequela Billable

  • T46.3X2S - Poisoning by coronary vasodilators, intentional self-harm, sequela Billable

  • T46.3X3S - Poisoning by coronary vasodilators, assault, sequela Billable

  • T46.3X4S - Poisoning by coronary vasodilators, undetermined, sequela Billable

  • T46.3X5 - Adverse effect of coronary vasodilators Non-Billable

  • T46.3X5A - Adverse effect of coronary vasodilators, initial encounter Billable

  • T46.3X5D - Adverse effect of coronary vasodilators, subsequent encounter Billable

  • T46.3X5S - Adverse effect of coronary vasodilators, sequela Billable

  • T46.3X6S - Underdosing of coronary vasodilators, sequela Billable

  • T46.4X1S - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela Billable

  • T46.4X2S - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela Billable

  • T46.4X3S - Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela Billable

  • T46.4X4S - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela Billable

  • T46.4X5 - Adverse effect of angiotensin-converting-enzyme inhibitors Non-Billable

  • T46.4X5A - Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter Billable

  • T46.4X5D - Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter Billable

  • T46.4X5S - Adverse effect of angiotensin-converting-enzyme inhibitors, sequela Billable

  • T46.4X6S - Underdosing of angiotensin-converting-enzyme inhibitors, sequela Billable

  • T46.5X1S - Poisoning by other antihypertensive drugs, accidental (unintentional), sequela Billable

  • T46.5X2S - Poisoning by other antihypertensive drugs, intentional self-harm, sequela Billable

  • T46.5X3S - Poisoning by other antihypertensive drugs, assault, sequela Billable

  • T46.5X4S - Poisoning by other antihypertensive drugs, undetermined, sequela Billable

  • T46.5X5 - Adverse effect of other antihypertensive drugs Non-Billable

  • T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter Billable

  • T46.5X5D - Adverse effect of other antihypertensive drugs, subsequent encounter Billable

  • T46.5X5S - Adverse effect of other antihypertensive drugs, sequela Billable

  • T46.5X6S - Underdosing of other antihypertensive drugs, sequela Billable

  • T46.6X1S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela Billable

  • T46.6X2S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela Billable

  • T46.6X3S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela Billable

  • T46.6X4S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela Billable

  • T46.6X5 - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs Non-Billable

  • T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter Billable

  • T46.6X5D - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter Billable

  • T46.6X5S - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable

  • T46.6X6S - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable

  • T46.7X1S - Poisoning by peripheral vasodilators, accidental (unintentional), sequela Billable

  • T46.7X2S - Poisoning by peripheral vasodilators, intentional self-harm, sequela Billable

  • T46.7X3S - Poisoning by peripheral vasodilators, assault, sequela Billable

  • T46.7X4S - Poisoning by peripheral vasodilators, undetermined, sequela Billable

  • T46.7X5 - Adverse effect of peripheral vasodilators Non-Billable

  • T46.7X5A - Adverse effect of peripheral vasodilators, initial encounter Billable

  • T46.7X5D - Adverse effect of peripheral vasodilators, subsequent encounter Billable

  • T46.7X5S - Adverse effect of peripheral vasodilators, sequela Billable

  • T46.7X6S - Underdosing of peripheral vasodilators, sequela Billable

  • T46.8X1S - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela Billable

  • T46.8X2S - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela Billable

  • T46.8X3S - Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela Billable

  • T46.8X4S - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela Billable

  • T46.8X5 - Adverse effect of antivaricose drugs, including sclerosing agents Non-Billable

  • T46.8X5A - Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter Billable

  • T46.8X5D - Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter Billable

  • T46.8X5S - Adverse effect of antivaricose drugs, including sclerosing agents, sequela Billable

  • T46.8X6S - Underdosing of antivaricose drugs, including sclerosing agents, sequela Billable

  • T46.901S - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable

  • T46.902S - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable

  • T46.903S - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela Billable

  • T46.904S - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela Billable

  • T46.905 - Adverse effect of unspecified agents primarily affecting the cardiovascular system Non-Billable

  • T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter Billable

  • T46.905D - Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter Billable

  • T46.905S - Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela Billable

  • T46.906S - Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela Billable

  • T46.991S - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable

  • T46.992S - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable

  • T46.993S - Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela Billable

  • T46.994S - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela Billable

  • T46.995 - Adverse effect of other agents primarily affecting the cardiovascular system Non-Billable

  • T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter Billable

  • T46.995D - Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter Billable

  • T46.995S - Adverse effect of other agents primarily affecting the cardiovascular system, sequela Billable

  • T46.996S - Underdosing of other agents primarily affecting the cardiovascular system, sequela Billable

  • T47.0X1S - Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela Billable

  • T47.0X2S - Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela Billable

  • T47.0X3S - Poisoning by histamine H2-receptor blockers, assault, sequela Billable

  • T47.0X4S - Poisoning by histamine H2-receptor blockers, undetermined, sequela Billable

  • T47.0X5 - Adverse effect of histamine H2-receptor blockers Non-Billable

  • T47.0X5A - Adverse effect of histamine H2-receptor blockers, initial encounter Billable

  • T47.0X5D - Adverse effect of histamine H2-receptor blockers, subsequent encounter Billable

  • T47.0X5S - Adverse effect of histamine H2-receptor blockers, sequela Billable

  • T47.0X6S - Underdosing of histamine H2-receptor blockers, sequela Billable

  • T47.1X1S - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela Billable

  • T47.1X2S - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela Billable

  • T47.1X3S - Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela Billable

  • T47.1X4S - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela Billable

  • T47.1X5 - Adverse effect of other antacids and anti-gastric-secretion drugs Non-Billable

  • T47.1X5A - Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter Billable

  • T47.1X5D - Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter Billable

  • T47.1X5S - Adverse effect of other antacids and anti-gastric-secretion drugs, sequela Billable

  • T47.1X6S - Underdosing of other antacids and anti-gastric-secretion drugs, sequela Billable

  • T47.2X1S - Poisoning by stimulant laxatives, accidental (unintentional), sequela Billable

  • T47.2X2S - Poisoning by stimulant laxatives, intentional self-harm, sequela Billable

  • T47.2X3S - Poisoning by stimulant laxatives, assault, sequela Billable

  • T47.2X4S - Poisoning by stimulant laxatives, undetermined, sequela Billable

  • T47.2X5 - Adverse effect of stimulant laxatives Non-Billable

  • T47.2X5A - Adverse effect of stimulant laxatives, initial encounter Billable

  • T47.2X5D - Adverse effect of stimulant laxatives, subsequent encounter Billable

  • T47.2X5S - Adverse effect of stimulant laxatives, sequela Billable

  • T47.2X6S - Underdosing of stimulant laxatives, sequela Billable

  • T47.3X1S - Poisoning by saline and osmotic laxatives, accidental (unintentional), sequela Billable

  • T47.3X2S - Poisoning by saline and osmotic laxatives, intentional self-harm, sequela Billable

  • T47.3X3S - Poisoning by saline and osmotic laxatives, assault, sequela Billable

  • T47.3X4S - Poisoning by saline and osmotic laxatives, undetermined, sequela Billable

  • T47.3X5 - Adverse effect of saline and osmotic laxatives Non-Billable

  • T47.3X5A - Adverse effect of saline and osmotic laxatives, initial encounter Billable

  • T47.3X5D - Adverse effect of saline and osmotic laxatives, subsequent encounter Billable

  • T47.3X5S - Adverse effect of saline and osmotic laxatives, sequela Billable

  • T47.3X6S - Underdosing of saline and osmotic laxatives, sequela Billable

  • T47.4X1S - Poisoning by other laxatives, accidental (unintentional), sequela Billable

  • T47.4X2S - Poisoning by other laxatives, intentional self-harm, sequela Billable

  • T47.4X3S - Poisoning by other laxatives, assault, sequela Billable

  • T47.4X4S - Poisoning by other laxatives, undetermined, sequela Billable

  • T47.4X5 - Adverse effect of other laxatives Non-Billable

  • T47.4X5A - Adverse effect of other laxatives, initial encounter Billable

  • T47.4X5D - Adverse effect of other laxatives, subsequent encounter Billable

  • T47.4X5S - Adverse effect of other laxatives, sequela Billable

  • T47.4X6S - Underdosing of other laxatives, sequela Billable

  • T47.5X1S - Poisoning by digestants, accidental (unintentional), sequela Billable

  • T47.5X2S - Poisoning by digestants, intentional self-harm, sequela Billable

  • T47.5X3S - Poisoning by digestants, assault, sequela Billable

  • T47.5X4S - Poisoning by digestants, undetermined, sequela Billable

  • T47.5X5 - Adverse effect of digestants Non-Billable

  • T47.5X5A - Adverse effect of digestants, initial encounter Billable

  • T47.5X5D - Adverse effect of digestants, subsequent encounter Billable

  • T47.5X5S - Adverse effect of digestants, sequela Billable

  • T47.5X6S - Underdosing of digestants, sequela Billable

  • T47.6X1S - Poisoning by antidiarrheal drugs, accidental (unintentional), sequela Billable

  • T47.6X2S - Poisoning by antidiarrheal drugs, intentional self-harm, sequela Billable

  • T47.6X3S - Poisoning by antidiarrheal drugs, assault, sequela Billable

  • T47.6X4S - Poisoning by antidiarrheal drugs, undetermined, sequela Billable

  • T47.6X5 - Adverse effect of antidiarrheal drugs Non-Billable

  • T47.6X5A - Adverse effect of antidiarrheal drugs, initial encounter Billable

  • T47.6X5D - Adverse effect of antidiarrheal drugs, subsequent encounter Billable

  • T47.6X5S - Adverse effect of antidiarrheal drugs, sequela Billable

  • T47.6X6S - Underdosing of antidiarrheal drugs, sequela Billable

  • T47.7X1S - Poisoning by emetics, accidental (unintentional), sequela Billable

  • T47.7X2S - Poisoning by emetics, intentional self-harm, sequela Billable

  • T47.7X3S - Poisoning by emetics, assault, sequela Billable

  • T47.7X4S - Poisoning by emetics, undetermined, sequela Billable

  • T47.7X5 - Adverse effect of emetics Non-Billable

  • T47.7X5A - Adverse effect of emetics, initial encounter Billable

  • T47.7X5D - Adverse effect of emetics, subsequent encounter Billable

  • T47.7X5S - Adverse effect of emetics, sequela Billable

  • T47.7X6S - Underdosing of emetics, sequela Billable

  • T47.8X1S - Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela Billable

  • T47.8X2S - Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela Billable

  • T47.8X3S - Poisoning by other agents primarily affecting gastrointestinal system, assault, sequela Billable

  • T47.8X4S - Poisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela Billable

  • T47.8X5 - Adverse effect of other agents primarily affecting gastrointestinal system Non-Billable

  • T47.8X5A - Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter Billable

  • T47.8X5D - Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter Billable

  • T47.8X5S - Adverse effect of other agents primarily affecting gastrointestinal system, sequela Billable

  • T47.8X6S - Underdosing of other agents primarily affecting gastrointestinal system, sequela Billable

  • T47.91XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela Billable

  • T47.92XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela Billable

  • T47.93XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela Billable

  • T47.94XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela Billable

  • T47.95 - Adverse effect of unspecified agents primarily affecting the gastrointestinal system Non-Billable

  • T47.95XA - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter Billable

  • T47.95XD - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter Billable

  • T47.95XS - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela Billable

  • T47.96XS - Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela Billable

  • T50.0X1S - Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela Billable

  • T50.0X2S - Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela Billable

  • T50.0X3S - Poisoning by mineralocorticoids and their antagonists, assault, sequela Billable

  • T50.0X4S - Poisoning by mineralocorticoids and their antagonists, undetermined, sequela Billable

  • T50.0X5 - Adverse effect of mineralocorticoids and their antagonists Non-Billable

  • T50.0X5A - Adverse effect of mineralocorticoids and their antagonists, initial encounter Billable

  • T50.0X5D - Adverse effect of mineralocorticoids and their antagonists, subsequent encounter Billable

  • T50.0X5S - Adverse effect of mineralocorticoids and their antagonists, sequela Billable

  • T50.0X6S - Underdosing of mineralocorticoids and their antagonists, sequela Billable

  • T50.1X1S - Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), sequela Billable

  • T50.1X2S - Poisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela Billable

  • T50.1X3S - Poisoning by loop [high-ceiling] diuretics, assault, sequela Billable

  • T50.1X4S - Poisoning by loop [high-ceiling] diuretics, undetermined, sequela Billable

  • T50.1X5 - Adverse effect of loop [high-ceiling] diuretics Non-Billable

  • T50.1X5A - Adverse effect of loop [high-ceiling] diuretics, initial encounter Billable

  • T50.1X5D - Adverse effect of loop [high-ceiling] diuretics, subsequent encounter Billable

  • T50.1X5S - Adverse effect of loop [high-ceiling] diuretics, sequela Billable

  • T50.1X6S - Underdosing of loop [high-ceiling] diuretics, sequela Billable

  • T50.2X1S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), sequela Billable

  • T50.2X2S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela Billable

  • T50.2X3S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela Billable

  • T50.2X4S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, sequela Billable

  • T50.2X5 - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics Non-Billable

  • T50.2X5A - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter Billable

  • T50.2X5D - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter Billable

  • T50.2X5S - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela Billable

  • T50.2X6S - Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela Billable

  • T50.3X1S - Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), sequela Billable

  • T50.3X2S - Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela Billable

  • T50.3X3S - Poisoning by electrolytic, caloric and water-balance agents, assault, sequela Billable

  • T50.3X4S - Poisoning by electrolytic, caloric and water-balance agents, undetermined, sequela Billable

  • T50.3X5 - Adverse effect of electrolytic, caloric and water-balance agents Non-Billable

  • T50.3X5A - Adverse effect of electrolytic, caloric and water-balance agents, initial encounter Billable

  • T50.3X5D - Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter Billable

  • T50.3X5S - Adverse effect of electrolytic, caloric and water-balance agents, sequela Billable

  • T50.3X6S - Underdosing of electrolytic, caloric and water-balance agents, sequela Billable

  • T50.4X1S - Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), sequela Billable

  • T50.4X2S - Poisoning by drugs affecting uric acid metabolism, intentional self-harm, sequela Billable

  • T50.4X3S - Poisoning by drugs affecting uric acid metabolism, assault, sequela Billable

  • T50.4X4S - Poisoning by drugs affecting uric acid metabolism, undetermined, sequela Billable

  • T50.4X5 - Adverse effect of drugs affecting uric acid metabolism Non-Billable

  • T50.4X5A - Adverse effect of drugs affecting uric acid metabolism, initial encounter Billable

  • T50.4X5D - Adverse effect of drugs affecting uric acid metabolism, subsequent encounter Billable

  • T50.4X5S - Adverse effect of drugs affecting uric acid metabolism, sequela Billable

  • T50.4X6S - Underdosing of drugs affecting uric acid metabolism, sequela Billable

  • T50.5X1S - Poisoning by appetite depressants, accidental (unintentional), sequela Billable

  • T50.5X2S - Poisoning by appetite depressants, intentional self-harm, sequela Billable

  • T50.5X3S - Poisoning by appetite depressants, assault, sequela Billable

  • T50.5X4S - Poisoning by appetite depressants, undetermined, sequela Billable

  • T50.5X5 - Adverse effect of appetite depressants Non-Billable

  • T50.5X5A - Adverse effect of appetite depressants, initial encounter Billable

  • T50.5X5D - Adverse effect of appetite depressants, subsequent encounter Billable

  • T50.5X5S - Adverse effect of appetite depressants, sequela Billable

  • T50.5X6S - Underdosing of appetite depressants, sequela Billable

  • T50.6X1S - Poisoning by antidotes and chelating agents, accidental (unintentional), sequela Billable

  • T50.6X2S - Poisoning by antidotes and chelating agents, intentional self-harm, sequela Billable

  • T50.6X3S - Poisoning by antidotes and chelating agents, assault, sequela Billable

  • T50.6X4S - Poisoning by antidotes and chelating agents, undetermined, sequela Billable

  • T50.6X5 - Adverse effect of antidotes and chelating agents Non-Billable

  • T50.6X5A - Adverse effect of antidotes and chelating agents, initial encounter Billable

  • T50.6X5D - Adverse effect of antidotes and chelating agents, subsequent encounter Billable

  • T50.6X5S - Adverse effect of antidotes and chelating agents, sequela Billable

  • T50.6X6S - Underdosing of antidotes and chelating agents, sequela Billable

  • T50.7X1S - Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), sequela Billable

  • T50.7X2S - Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, sequela Billable

  • T50.7X3S - Poisoning by analeptics and opioid receptor antagonists, assault, sequela Billable

  • T50.7X4S - Poisoning by analeptics and opioid receptor antagonists, undetermined, sequela Billable

  • T50.7X5 - Adverse effect of analeptics and opioid receptor antagonists Non-Billable

  • T50.7X5A - Adverse effect of analeptics and opioid receptor antagonists, initial encounter Billable

  • T50.7X5D - Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter Billable

  • T50.7X5S - Adverse effect of analeptics and opioid receptor antagonists, sequela Billable

  • T50.7X6S - Underdosing of analeptics and opioid receptor antagonists, sequela Billable

  • T50.8X1S - Poisoning by diagnostic agents, accidental (unintentional), sequela Billable

  • T50.8X2S - Poisoning by diagnostic agents, intentional self-harm, sequela Billable

  • T50.8X3S - Poisoning by diagnostic agents, assault, sequela Billable

  • T50.8X4S - Poisoning by diagnostic agents, undetermined, sequela Billable

  • T50.8X5 - Adverse effect of diagnostic agents Non-Billable

  • T50.8X5A - Adverse effect of diagnostic agents, initial encounter Billable

  • T50.8X5D - Adverse effect of diagnostic agents, subsequent encounter Billable

  • T50.8X5S - Adverse effect of diagnostic agents, sequela Billable

  • T50.8X6S - Underdosing of diagnostic agents, sequela Billable

  • T50.901S - Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela Billable

  • T50.902S - Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, sequela Billable

  • T50.903S - Poisoning by unspecified drugs, medicaments and biological substances, assault, sequela Billable

  • T50.904S - Poisoning by unspecified drugs, medicaments and biological substances, undetermined, sequela Billable

  • T50.905 - Adverse effect of unspecified drugs, medicaments and biological substances Non-Billable

  • T50.905A - Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter Billable

  • T50.905D - Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter Billable

  • T50.905S - Adverse effect of unspecified drugs, medicaments and biological substances, sequela Billable

  • T50.906S - Underdosing of unspecified drugs, medicaments and biological substances, sequela Billable

  • T50.911S - Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela Billable

  • T50.912S - Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, sequela Billable

  • T50.913S - Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, sequela Billable

  • T50.914S - Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, sequela Billable

  • T50.915 - Adverse effect of multiple unspecified drugs, medicaments and biological substances Non-Billable

  • T50.915A - Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter Billable

  • T50.915D - Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter Billable

  • T50.915S - Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela Billable

  • T50.916S - Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela Billable

  • T50.991S - Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), sequela Billable

  • T50.992S - Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela Billable

  • T50.993S - Poisoning by other drugs, medicaments and biological substances, assault, sequela Billable

  • T50.994S - Poisoning by other drugs, medicaments and biological substances, undetermined, sequela Billable

  • T50.995 - Adverse effect of other drugs, medicaments and biological substances Non-Billable

  • T45.7X1S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela Billable

  • T45.7X2S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela Billable

  • T45.7X3S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela Billable

  • T45.7X4S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela Billable

  • T45.7X5 - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants Non-Billable

  • T45.7X5A - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter Billable

  • T45.7X5D - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter Billable

  • T45.7X5S - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela Billable

  • T45.7X6S - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela Billable

  • T45.8X1S - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela Billable

  • T45.8X2S - Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela Billable

  • T45.8X3S - Poisoning by other primarily systemic and hematological agents, assault, sequela Billable

  • T45.8X4S - Poisoning by other primarily systemic and hematological agents, undetermined, sequela Billable

  • T45.8X5 - Adverse effect of other primarily systemic and hematological agents Non-Billable

  • T45.8X5A - Adverse effect of other primarily systemic and hematological agents, initial encounter Billable

  • T45.8X5D - Adverse effect of other primarily systemic and hematological agents, subsequent encounter Billable

  • T45.8X5S - Adverse effect of other primarily systemic and hematological agents, sequela Billable

  • T45.8X6S - Underdosing of other primarily systemic and hematological agents, sequela Billable

  • T45.91XS - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela Billable

  • T45.92XS - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela Billable

  • T45.93XS - Poisoning by unspecified primarily systemic and hematological agent, assault, sequela Billable

  • T45.94XS - Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela Billable

  • T45.95 - Adverse effect of unspecified primarily systemic and hematological agent Non-Billable

  • T45.95XA - Adverse effect of unspecified primarily systemic and hematological agent, initial encounter Billable

  • T45.95XD - Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter Billable

  • T45.95XS - Adverse effect of unspecified primarily systemic and hematological agent, sequela Billable

  • T45.96XS - Underdosing of unspecified primarily systemic and hematological agent, sequela Billable

  • T45.AX5 - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs Non-Billable

  • T49.0X1S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), sequela Billable

  • T49.0X2S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, sequela Billable

  • T49.0X3S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, sequela Billable

  • T49.0X4S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, sequela Billable

  • T49.0X5 - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs Non-Billable

  • T49.0X5A - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter Billable

  • T49.0X5D - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter Billable

  • T49.0X5S - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela Billable

  • T49.0X6S - Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela Billable

  • T49.1X1S - Poisoning by antipruritics, accidental (unintentional), sequela Billable

  • T49.1X2S - Poisoning by antipruritics, intentional self-harm, sequela Billable

  • T49.1X3S - Poisoning by antipruritics, assault, sequela Billable

  • T49.1X4S - Poisoning by antipruritics, undetermined, sequela Billable

  • T49.1X5 - Adverse effect of antipruritics Non-Billable

  • T49.1X5A - Adverse effect of antipruritics, initial encounter Billable

  • T49.1X5D - Adverse effect of antipruritics, subsequent encounter Billable

  • T49.1X5S - Adverse effect of antipruritics, sequela Billable

  • T49.1X6S - Underdosing of antipruritics, sequela Billable

  • T49.2X1S - Poisoning by local astringents and local detergents, accidental (unintentional), sequela Billable

  • T49.2X2S - Poisoning by local astringents and local detergents, intentional self-harm, sequela Billable

  • T49.2X3S - Poisoning by local astringents and local detergents, assault, sequela Billable

  • T49.2X4S - Poisoning by local astringents and local detergents, undetermined, sequela Billable

  • T49.2X5 - Adverse effect of local astringents and local detergents Non-Billable

  • T49.2X5A - Adverse effect of local astringents and local detergents, initial encounter Billable

  • T49.2X5D - Adverse effect of local astringents and local detergents, subsequent encounter Billable

  • T49.2X5S - Adverse effect of local astringents and local detergents, sequela Billable

  • T49.2X6S - Underdosing of local astringents and local detergents, sequela Billable

  • T49.3X1S - Poisoning by emollients, demulcents and protectants, accidental (unintentional), sequela Billable

  • T49.3X2S - Poisoning by emollients, demulcents and protectants, intentional self-harm, sequela Billable

  • T49.3X3S - Poisoning by emollients, demulcents and protectants, assault, sequela Billable

  • T49.3X4S - Poisoning by emollients, demulcents and protectants, undetermined, sequela Billable

  • T49.3X5 - Adverse effect of emollients, demulcents and protectants Non-Billable

  • T49.3X5A - Adverse effect of emollients, demulcents and protectants, initial encounter Billable

  • T49.3X5D - Adverse effect of emollients, demulcents and protectants, subsequent encounter Billable

  • T49.3X5S - Adverse effect of emollients, demulcents and protectants, sequela Billable

  • T49.3X6S - Underdosing of emollients, demulcents and protectants, sequela Billable

  • T49.4X1S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), sequela Billable

  • T49.4X2S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, sequela Billable

  • T49.4X3S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, sequela Billable

  • T49.4X4S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, sequela Billable

  • T49.4X5 - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations Non-Billable

  • T49.4X5A - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter Billable

  • T49.4X5D - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter Billable

  • T49.4X5S - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela Billable

  • T49.4X6S - Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela Billable

  • T49.5X1S - Poisoning by ophthalmological drugs and preparations, accidental (unintentional), sequela Billable

  • T49.5X2S - Poisoning by ophthalmological drugs and preparations, intentional self-harm, sequela Billable

  • T49.5X3S - Poisoning by ophthalmological drugs and preparations, assault, sequela Billable

  • T49.5X4S - Poisoning by ophthalmological drugs and preparations, undetermined, sequela Billable

  • T49.5X5 - Adverse effect of ophthalmological drugs and preparations Non-Billable

  • T49.5X5A - Adverse effect of ophthalmological drugs and preparations, initial encounter Billable

  • T49.5X5D - Adverse effect of ophthalmological drugs and preparations, subsequent encounter Billable

  • T49.5X5S - Adverse effect of ophthalmological drugs and preparations, sequela Billable

  • T49.5X6S - Underdosing of ophthalmological drugs and preparations, sequela Billable

  • T49.6X1S - Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), sequela Billable

  • T49.6X2S - Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, sequela Billable

  • T49.6X3S - Poisoning by otorhinolaryngological drugs and preparations, assault, sequela Billable

  • T49.6X4S - Poisoning by otorhinolaryngological drugs and preparations, undetermined, sequela Billable

  • T49.6X5 - Adverse effect of otorhinolaryngological drugs and preparations Non-Billable

  • T49.6X5A - Adverse effect of otorhinolaryngological drugs and preparations, initial encounter Billable

  • T49.6X5D - Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter Billable

  • T49.6X5S - Adverse effect of otorhinolaryngological drugs and preparations, sequela Billable

  • T49.6X6S - Underdosing of otorhinolaryngological drugs and preparations, sequela Billable

  • T49.7X1S - Poisoning by dental drugs, topically applied, accidental (unintentional), sequela Billable

  • T49.7X2S - Poisoning by dental drugs, topically applied, intentional self-harm, sequela Billable

  • T49.7X3S - Poisoning by dental drugs, topically applied, assault, sequela Billable

  • T49.7X4S - Poisoning by dental drugs, topically applied, undetermined, sequela Billable

  • T49.7X5 - Adverse effect of dental drugs, topically applied Non-Billable

  • T49.7X5A - Adverse effect of dental drugs, topically applied, initial encounter Billable

  • T49.7X5D - Adverse effect of dental drugs, topically applied, subsequent encounter Billable

  • T49.7X5S - Adverse effect of dental drugs, topically applied, sequela Billable

  • T49.7X6S - Underdosing of dental drugs, topically applied, sequela Billable

  • T49.8X1S - Poisoning by other topical agents, accidental (unintentional), sequela Billable

  • T49.8X2S - Poisoning by other topical agents, intentional self-harm, sequela Billable

  • T49.8X3S - Poisoning by other topical agents, assault, sequela Billable

  • T49.8X4S - Poisoning by other topical agents, undetermined, sequela Billable

  • T49.8X5 - Adverse effect of other topical agents Non-Billable

  • T49.8X5A - Adverse effect of other topical agents, initial encounter Billable

  • T49.8X5D - Adverse effect of other topical agents, subsequent encounter Billable

  • T49.8X5S - Adverse effect of other topical agents, sequela Billable

  • T49.8X6S - Underdosing of other topical agents, sequela Billable

  • T49.91XS - Poisoning by unspecified topical agent, accidental (unintentional), sequela Billable

  • T49.92XS - Poisoning by unspecified topical agent, intentional self-harm, sequela Billable

  • T49.93XS - Poisoning by unspecified topical agent, assault, sequela Billable

  • T49.94XS - Poisoning by unspecified topical agent, undetermined, sequela Billable

  • T49.95 - Adverse effect of unspecified topical agent Non-Billable

  • T49.95XA - Adverse effect of unspecified topical agent, initial encounter Billable

  • T49.95XD - Adverse effect of unspecified topical agent, subsequent encounter Billable

  • T49.95XS - Adverse effect of unspecified topical agent, sequela Billable

  • T49.96XS - Underdosing of unspecified topical agent, sequela Billable